Diagnostic Efficacy of Contrast-Enhanced Ultrasound in Patients with Chronic Viral Hepatitis

Aim: to determine the diagnostic efficiency of contrast-enhanced ultrasound of the liver in patients with chronic viral hepatitis B and C.

Study Design: open randomized study.

Materials and methods. 240 people were examined on the basis of the Smolensk Clinical Hospital No. 1 from 2019 to 2021: patients with chronic viral hepatitis who have been examined by contrast-enhanced ultrasound; patients with chronic viral hepatitis who have not been examined by contrast-enhanced ultrasound to determine the diagnostic effectiveness of the method in assessing the complicated course development, patients without chronic viral hepatitis who have been examined by contrast-enhanced ultrasound to determine the standardized CEUS parameters. Liver biopsy and shear wave elastography were used as reference methods.

Results. It was found that the greatest changes in contrast-enhanced ultrasound parameters were observed in patients with F4 fibrosis stage according to the METAVIR score. It was also found that the assessment of qualitative parameters according to the proposed standardized program has the highest diagnostic potential, and among the quantitative parameters — the difference of quantitative parameters in the proximal and distal zones (time of arrival, time to peak, peak intensity, half-time washout).

Conclusion. The use of a contrast agent increases the value of the ultrasound method in the diagnostic algorithm for patients with chronic viral hepatitis.

1. Sencha A.N. Ultrasound examination with the use of contrast agents. From simple to complex. Moscow; 2021. 296 p. (in Russian)

2. Dietrich C.F., Christian P.N., Richard G.B. et al. Guidelines and Good Clinical Practice Recommendations for Contrast Enhanced Ultrasound (CEUS) in the Liver — Update 2020: WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultraschall Med. 2020;41(5):562–585.

3. Weskott H.-P. Contrast-enhanced ultrasound. Bremen; 2014. 284 p.

4. Borsukov A.V. Contrast-enhanced ultrasound of the liver: evolution of the world experts opinions from 2012 to 2020. Journal of Oncology: Diagnostic Radiology and Radiotherapy. 2021;4(1):20–30. (in Russian). DOI: 10.37174/2587-7593-2021-4-1-20-30

5. Claudon M., Dietrich C.F., Choi B.I. et al. Guidelines and good clinical practice recommendations for contrast enchanced ultrasound (CEUS) in the liver — update 2012: a WFUMB — EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultrasound in Medicine and Biology. 2013;9(2):187–210. DOI: 10.1016/j.ultrasmedbio.2012.09.002

6. Mit'kov V.V., Sadokov V.M., Hitrova A.N. et al. Non-invasive dopplerographic diagnostics of liver cirrhosis on the basis of the transit-time analysis for the ultrasound contrast agent entering into the hepatic veins. Ultrasound & Functional Diagnostics. 2001;(2):14–18. (in Russian)

7. Ridolfi F., Abbattista T., Marini F. et al. Contrast-enchanced ultrasound to evaluate the severity of chronic hepatitis C. Digestive and Live Disease. 2007;39:929–935.

8. Shiff Yu.R., Sorrel M.F., Maddrey U.S. Viral hepatitis and cholestatic diseases. Moscow; 2010. 408 p. (in Russian)

9. Cosgrove D. Contrast-enchanced ultrasound of the liver. London; 2010:64.

10. Liu G.J., Lu M.D. Diagnosis of liver cirrhosis with contrast-enhanced ultrasound. World J. Radiol. 2010;2(1):32–36. DOI: 10.4329/wjr.v2.i1.32

11. European Association for the Study of the Liver 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J. Hepatol. 2017;67(2):370–398. DOI: 10.1016/j.jhep.2017.03.021

12. European Association for Study of Liver. EASL recommendations on treatment of hepatitis C: Final update of the series. J. Hepatol. 2020;73(5):1170–1218. DOI: 10.1016/j.jhep.2020.08.018

13. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 Hepatitis B Guidance. Hepatology. 2018;67(4):1560–1599. DOI: 10.1002/hep.29800

14. Hepatitis C Guidance 2018 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection. Clin. Infect. Dis. 2018;67(10):1477–1492. DOI: 10.1093/cid/ciy585

15. Borsukov A.V., Bueverov A.O., Tihankova A.V. Capabilities of contrast-enhanced ultrasound in the diagnosis of liver cirrhosis. Medicinskij alfavit. 2019. 2019;3(29):26–30. (in Russian)

16. Borsukov A.V., Tihankova A.V. A method for predicting the clinical course of diffuse liver diseases. Invention Patent RU 2713944, 11.02.2020. (in Russian)

17. Petrie A., Sabin K. Medical statistics at a glance. Hoboken; 2020. 4th ed.